...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Rampant bull on the science, but some concerns over the money end linger.

You have been missed! Carman

Share
New Message
Please login to post a reply